About Evoq Remedies Limited
Data last updated: 15 July 2026
Evoq Remedies Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 February 2010, the company has been in operation for over 16 years.
Registered with ROC Ahmedabad under CIN L46209GJ2010PLC059692. Listed on BSE: 543500.
Capital: an authorised share capital of ₹42 Cr and a paid-up capital of ₹24.9 Cr. Formerly known as Evoq Remedies Private Limited and Salus Life Science and Research Private Limited. It is led by directors including Bhumishth Narendrabhai Patel and Harsh Kothari.
Last AGM: 17 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹25.51 Cr, a growth of 116.96% compared to the previous year. The net worth stands at ₹44.3 Cr (down 0.54% YoY). Total assets are valued at ₹51.94 Cr (up 3.86% YoY).
The company is associated with 1 brand - Evoq Remedies.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evoqremedies.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressA – 1106 Empire Business Hub Near Auda Water Tank Science City Road, Sola, Ahmedabad, Gujarat, India – 380060
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Evoq Remedies Limited
Evoq Remedies Limited has undergone 2 name changes throughout its history. The company was previously known as Evoq Remedies Private Limited, and Salus Life Science And Research Private Limited. The current legal name is Evoq Remedies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Evoq Remedies Limited | Current |
| Evoq Remedies Private Limited | Previous |
| Salus Life Science And Research Private Limited | Previous |
CIN History of Evoq Remedies Limited
Evoq Remedies Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46209GJ2010PLC059692, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L46209GJ2010PLC059692 | Current |
| U24230GJ2010PLC059692 | Previous |
| L24230GJ2010PLC059692 | Previous |
| U24230GJ2010PTC059692 | Previous |
Associated Brands with Evoq Remedies Limited
Evoq Remedies Limited operates one associated brand: EVOQ Remedies. These brands represent Evoq Remedies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CDMO focused on manufacturing pharmaceutical formulation and marketing services | evoqremedies.com |
Competitors & Alternatives of Evoq Remedies Limited
Brands and companies operating in the same space as Evoq Remedies Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Dotmatics
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Beta Drugs
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Biomatter
|
Provider of synthetic biology and AI-based technology for generative protein design | Vilnius, Lithuania, Lithuania | 2018 |
Auditor Details of Evoq Remedies Limited
Evoq Remedies Limited is audited by H Thakkar & Co. LLP (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| H Thakkar & Co. LLP (ICAI peer reviewed, certificate valid till 2027-05-31) | FY 2026 | Statement on impact of audit qualification |
Board of Directors of Evoq Remedies Limited
Evoq Remedies Limited is currently managed by 4 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bhumishth Narendrabhai Patel
Also directs:
Evoq Remedies Limited, Patron Exim Limited, Aquilae Worldwide Private Limited and 5 more
|
Managing Director | 01 Aug 2024 | 2 Years 0 Months | Current |
|
Harsh Kothari
Also directs:
Evoq Remedies Limited, Eforu Entertainment Limited
|
Director | 06 Sep 2024 | 1 Years 11 Months | Current |
|
Pushpa Joshi
Also directs:
Evoq Remedies Limited, Vintage Coffee And Beverages Limited, Avi Polymers Limited and 5 more
|
Director | 31 Mar 2025 | 1 Years 4 Months | Current |
|
Narendrakumar Gangaramdas Patel
Also directs:
Evoq Remedies Limited, Patron Exim Limited, Aquilae Worldwide Private Limited and 5 more
|
Director | 11 Sep 2023 | 2 Years 11 Months | Current |
Financials of Evoq Remedies Limited FY 2026 filings available
Evoq Remedies Limited reported revenue of ₹25.51 Cr (up 116.96% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹25.51 Cr | ₹11.76 Cr | ₹4.05 Cr | ₹20.39 Cr | ₹16.78 Cr |
| Other Income | ₹1.25 Cr | ₹2.41 Cr | ₹2.26 Cr | ₹6.02 Cr | ₹0 |
| Total Income | ₹26.76 Cr | ₹14.17 Cr | - | - | - |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹20.58 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹24.93 Cr | ₹12.18 Cr | ₹2.65 Cr | ₹0 | ₹14.41 Cr |
| Changes in Inventories | ₹54.79 Lakh | ₹90.6 Lakh | -₹1.09 Cr | -₹1.25 Cr | -₹63.38 Lakh |
| Employee Benefit Expense | ₹6.89 Lakh | ₹6.82 Lakh | ₹7.75 Lakh | ₹20.39 Lakh | ₹17.3 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹13,000 | ₹46,000 |
| Other Expenses | ₹1.41 Cr | ₹84.45 Lakh | ₹4.06 Cr | ₹4.59 Cr | ₹1.37 Cr |
| Total Expenses | ₹27.01 Cr | ₹14.04 Cr | ₹5.7 Cr | ₹24.13 Cr | ₹15.32 Cr |
| Profit Before Tax | -₹25.1 Lakh | ₹12.82 Lakh | ₹61.14 Lakh | ₹2.28 Cr | ₹1.46 Cr |
| Total Tax Expense | -₹1.11 Lakh | ₹8.82 Lakh | ₹15.9 Lakh | ₹66.53 Lakh | ₹36.71 Lakh |
| Net Profit | -₹23.99 Lakh | ₹4 Lakh | ₹45.24 Lakh | ₹1.62 Cr | ₹1.09 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | ₹51.94 Cr | ₹50.01 Cr | ₹36.86 Cr | ₹34.9 Cr | ₹33.33 Cr |
| Non-current Assets | ₹17.2 Lakh | ₹22.31 Lakh | ₹1.4 Lakh | ₹93,000 | ₹0 |
| Current Assets | ₹51.77 Cr | ₹49.79 Cr | ₹36.85 Cr | ₹34.89 Cr | ₹33.33 Cr |
| Property, Plant & Equipment | ₹17.2 Lakh | ₹22.31 Lakh | - | - | - |
| Inventories | ₹1.67 Cr | ₹2.22 Cr | ₹3.13 Cr | ₹2.03 Cr | ₹78.44 Lakh |
| Cash & Equivalents | ₹52,000 | ₹21.41 Lakh | ₹12.34 Lakh | ₹15.36 Lakh | ₹3.09 Cr |
| Equity (Net Worth) | ₹44.3 Cr | ₹44.54 Cr | - | - | - |
| Current Liabilities | ₹7.64 Cr | ₹5.47 Cr | ₹11.62 Cr | ₹10.11 Cr | ₹10.17 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹28.19 Lakh | -₹14.62 Cr | ₹5.32 Cr | -₹4.35 Cr | -₹26.43 Cr |
| Investing Cash Flow | ₹0 | -₹25.81 Lakh | -₹1.2 Lakh | -₹1.31 Lakh | ₹0 |
| Financing Cash Flow | ₹7.3 Lakh | ₹14.97 Cr | -₹5.34 Cr | ₹1.42 Cr | ₹29.49 Cr |
| Capital Expenditure | ₹0 | ₹25.81 Lakh | - | - | - |
| Free Cash Flow (computed) | -₹28.19 Lakh | -₹14.88 Cr | - | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹20.89 Lakh | ₹9.07 Lakh | -₹3.02 Lakh | -₹2.94 Cr | ₹3.06 Cr |
Charges & Borrowings Evoq Remedies Limited
Evoq Remedies Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Evoq Remedies Limited
View historical data on people associated with Evoq Remedies Limited, including employment history and EPFO contributions.
Employee and EPFO history for Evoq Remedies Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Evoq Remedies Limited
GST registrations and filing compliance for Evoq Remedies Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Evoq Remedies Limited
Credit ratings, litigation, and regulatory alerts for Evoq Remedies Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Evoq Remedies Limited
MSME payment history for Evoq Remedies Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Evoq Remedies Limited
Corporate group structure for Evoq Remedies Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Evoq Remedies Limited
MCA filings and documents for Evoq Remedies Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Evoq Remedies Limited
Frequently Asked Questions about Evoq Remedies Limited
Evoq Remedies Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 24 February 2010 (16+ years old) and is registered under CIN L46209GJ2010PLC059692. Listed on BSE: 543500.
Evoq Remedies Limited reported revenue of ₹25.51 Cr for FY 2026 (up 116.96% YoY) based on standalone BSE filings.
The current directors of Evoq Remedies Limited are:
- Bhumishth Narendrabhai Patel - Managing Director
- Harsh Kothari - Director
- Pushpa Joshi - Director
- Narendrakumar Gangaramdas Patel - Director
The primary industry of Evoq Remedies Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Evoq Remedies Limited is listed on BSE with code 543500.
Evoq Remedies Limited can be reached at the registered office: A – 1106 Empire Business Hub Near Auda Water Tank Science City Road, Sola, Ahmedabad, Gujarat, India – 380060, or through the website evoqremedies.com.